Healthcare · Drug Manufacturers - Specialty & Generic

Hims & Hers Health, Inc.

NASDAQ: HIMS ·USD ·United States

Co-Founder, Chairman & CEO Mr. Andrew Dudum

48 Months —

Price Chart

Last 12 months · daily close · updated after market close

12-Month Chart

— —

Key Metrics

Updated May 10, 2026

52 Week Range

13.74 – 70.43

Day Range

24.57 – 26.84

EPS (FWD)

1.38

PE (TTM)

55.43

PE (FWD)

20.50

Div Rate (FWD)

—

Yield (FWD)

—

Short Interest

37.25%

Market Cap

$6.53 B

Prev. Close

29.14

Analyst Consensus

Consensus Rating

HOLD

Analysts

covering this stock

Mean Target

$26.04

-0.1% vs current

Current Price

$26.05

-10.60% today

12-Month Price Target Range

MEAN TARGET

$26.04

NOW $26.05

LOW TARGET

$18.00

HIGH TARGET

$35.00

Range based on 14 Wall Street analysts covering HIMS.

Recent Analyst Actions — 8 unique firms, latest first

May 12, 2026 Reiterate BTIG Neutral
May 12, 2026 Maintain Needham Buy (+$30 → $35)
Apr 24, 2026 Init JP Morgan Overweight PT $35
Apr 24, 2026 Maintain B of A Securities Neutral (+$30 → $32)
Mar 27, 2026 Maintain TD Cowen Hold ($25 → $23)
Mar 16, 2026 Maintain Leerink Partners Market Perform (+$18 → $25)
Mar 11, 2026 Maintain Barclays Overweight (+$25 → $29)
Mar 10, 2026 Upgrade Citigroup Sell → Neutral (+$13 → $24)

Website: www.forhims.com ↗
ISIN: US4330001060

Quarter	Revenue	YoY	Net Income	EPS (Diluted)	YoY	Gross Margin	Op. Margin
Q4 2025 Dec 2025	$617.8M	+28.4%	$20.6M	$0.08	-27.3%	71.9%	1.5%
Q3 2025 Sep 2025	$599.0M	—	$15.8M	$0.06	—	73.8%	2.0%
Q2 2025 Jun 2025	$544.8M	—	$42.5M	$0.17	—	76.4%	4.9%
Q1 2025 Mar 2025	$586.0M	—	$49.5M	$0.20	—	73.5%	9.9%
Q4 2024 Dec 2024	$481.1M	—	$26.0M	$0.11	—	76.8%	3.9%

Data from Yahoo Finance. YoY compares the same quarter of the prior fiscal year.

Metric	Current	Forward
EPS	—	$1.38
Revenue	—	$2.35 B
P/E	55.43	20.50
Dividend	—	—
Profit Margin	5.47%	—
PEG Ratio	2.43	—
Beta (5Y)	2.42	—

Rate (FWD): —
Yield (FWD): —
Payout Ratio: 0.00%
Ex-Div Date: —

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.